- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04578925
Happy, Healthy, Loved: A Mobile-delivered Breastfeeding Self-efficacy Intervention for First Time Parents (HHL)
July 13, 2023 updated by: OhioHealth
The purpose of this study is to test if a mobile device delivered intervention program can improve breast-feeding self-efficacy in primiparous mothers.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The proposed study will test if a mobile device based intervention program, called "Happy, Healthy, Loved (HHL)", will impact breast feeding rates and breastfeeding self-efficacy when compared to care as usual.
Primiparous women and their partners will be randomly assigned to the HHL program or usual care.
Study Type
Interventional
Enrollment (Actual)
128
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43214
- OhioHealth
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- primiparous mothers,
- living with a partner or spouse,
- have an intention to breastfeed their infant for at least 6-weeks postpartum;
- whose infant is not in the Neonatal Intensive Care Unit,
- have a mobile phone with text message capability,
- have no current self-reported depressive episode, and;
- English as a primary language
Exclusion Criteria:
- mothers who have other biological children,
- have infants in the Neonatal Intensive Care Unit,
- do not have a mobile phone with text message capabilities,
- report current episodes of depression, or are receiving antidepressant treatment or psychotherapy for depression,
- have initial study survey that indicates suicide risks (participants who are identified as suicidal ideation at 6 weeks or 6 months will receive further assessment and referral but not be excluded from the program because it may be more harmful and penalizing to remove them from the program if they find it helpful. We will remind the participant that continuing is voluntary and there is no penalty if they wish to discontinue participation)
- do not speak, read and write English
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Happy, Healthy, Loved
Both parents will complete surveys on a tablet during the postpartum hospital stay.
Surveys cover three topic areas related to breast-feeding; modeling and feedback, partner support, and stress coping.
For the next 6 weeks participants' will receive 4 personalized text messages per week based on their tablet survey responses.
Participants will be asked one yes/no question each week ("still breastfeeding?
Text Y for yes, N for no").
Once a "no" response has been received from a participant, all remaining text messages will emphasize coping and partner support rather than breastfeeding.
|
A text message based, mobile-device delivered intervention that provides educational information to primiparous mothers and their partners about breast-feeding and coping with stress.
|
|
No Intervention: Control
Control group participants will complete surveys on a tablet during the postpartum hospital stay.
Surveys cover three topic areas related to breast-feeding; modeling and feedback, partner support, and stress coping.
The control group participants will be sent 4 text messages per week for the first 6 weeks, but the content of the texts will be non-breastfeeding related.
The content will instead summarize infant development facts.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Breastfeeding Self-Efficacy: Breastfeeding self-efficacy scale short form
Time Frame: 6 weeks postpartum
|
Breastfeeding self-efficacy scale short form (McCarter-Spaulding & Dennis, 2010)- The Breastfeeding self-efficacy scale short form (BSES-SF) will be used to measure breastfeeding self-efficacy.
The scores for this scale range from 1-5, with higher scores indicating greater self-efficacy related to breastfeeding.
|
6 weeks postpartum
|
|
Breastfeeding Self-Efficacy: Breastfeeding self-efficacy scale short form
Time Frame: 6 months postpartum
|
Breastfeeding self-efficacy scale short form (McCarter-Spaulding & Dennis, 2010)- The Breastfeeding self-efficacy scale short form (BSES-SF) will be used to measure breastfeeding self-efficacy.
The scores for this scale range from 1-5, with higher scores indicating greater self-efficacy related to breastfeeding.
|
6 months postpartum
|
|
Breastfeeding Rate
Time Frame: 6 weeks postpartum
|
Index of breastfeeding status - Women will be asked to identify the level that accurately described their breastfeeding behaviors within the previous 24 hours.
Four levels will be reported: exclusive breastfeeding (breast milk only), partial breastfeeding (breast milk and at least 1 bottle of formula per day), token breastfeeding (breast given to comfort baby not for nutrition), and no breastfeeding.
Higher values represent more exclusive breastfeeding.
|
6 weeks postpartum
|
|
Breastfeeding Rate
Time Frame: 6 months postpartum
|
Index of breastfeeding status - Women will be asked to identify the level that accurately described their breastfeeding behaviors within the previous 24 hours.
Four levels will be reported: exclusive breastfeeding (breast milk only), partial breastfeeding (breast milk and at least 1 bottle of formula per day), token breastfeeding (breast given to comfort baby not for nutrition), and no breastfeeding.
Higher values represent more exclusive breastfeeding.
|
6 months postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Coping Behavior
Time Frame: 6 weeks postpartum
|
Brief Coping Orientation to Problems Experienced (COPE) - This 28-item validated scale derived from a previously published measure showing reliability and convergent validity with several established coping measures will be used to identify coping strategies consistent with cognitive-behavioral skills.
The scale assesses frequency with which a person uses coping strategies rated on a scale of 1-4.
The higher the number indicates a higher frequency.
|
6 weeks postpartum
|
|
Coping Behavior
Time Frame: 6 months postpartum
|
Brief Coping Orientation to Problems Experienced (COPE) - This 28-item validated scale derived from a previously published measure showing reliability and convergent validity with several established coping measures will be used to identify coping strategies consistent with cognitive-behavioral skills.
The scale assesses frequency with which a person uses coping strategies rated on a scale of 1-4.
The higher the number indicates a higher frequency.
|
6 months postpartum
|
|
Postpartum Partner Support
Time Frame: 6 weeks postpartum
|
Postpartum Partner Support Scale (PPSS) - The PPSS is a 24-item self-report instrument to assess partner postpartum-specific support.
Items are rated on a 4-point Likert-type scale (responses from 1-4) to produce a total score ranging from 24 to 96, with higher scores indicating higher levels of postpartum partner support.
|
6 weeks postpartum
|
|
Partner Support
Time Frame: 6 weeks postpartum
|
Social Provisions Checklist - This is a 30-item measure of perceived support from the co-parent.
The scale covers six provisions of support: guidance, reliable alliance, reassurance of worth, attachment, social integration, and opportunity for nurturance.
All items are rated on a 5-point scale for a total score of between 30-120, with higher scores indicating higher levels of support.
|
6 weeks postpartum
|
|
Postpartum Partner Support
Time Frame: 6 months postpartum
|
Postpartum Partner Support Scale (PPSS) - The PPSS is a 24-item self-report instrument to assess partner postpartum-specific support.
Items are rated on a 4-point Likert-type scale (responses from 1-4) to produce a total score ranging from 24 to 96, with higher scores indicating higher levels of postpartum partner support.
|
6 months postpartum
|
|
Partner Support
Time Frame: 6 months postpartum
|
Social Provisions Checklist - This is a 30-item measure of perceived support from the co-parent.
The scale covers six provisions of support: guidance, reliable alliance, reassurance of worth, attachment, social integration, and opportunity for nurturance.
All items are rated on a 5-point scale for a total score of between 30-120, with higher scores indicating higher levels of support.
|
6 months postpartum
|
|
Hair Cortisol
Time Frame: 0-2 days postpartum
|
A small amount (15-30 mg) of hair from the posterior vertex of the head will be collected.
Hair strands will then be cut into 3 cm segments, which based on human scalp hair grows at approximately 1 cm per month, so each of the 3 cm samples will index cortisol output during the three trimesters of pregnancy.
If hair is less than 9 cm long, the analysis will include only the number of 3 cm segments available.
The wash procedure and steroid extraction will be undertaken using high performance liquid chromatography-mass spectrometry.
Additionally, mothers will be asked about their hair histories to use as covariates in analysis along with hair sample.
Hair histories include questions related to hair color, salon treatments, sunlight exposure, use of hair products, medications, creams, and hair pieces, style and indoor tanning habits.
|
0-2 days postpartum
|
|
Sleep Quality (hair cortisol covariate): Pittsburgh Sleep Quality Index (PSQI)
Time Frame: 0-2 days postpartum
|
Pittsburgh Sleep Quality Index (PSQI) - This scale assesses sleep quality, which is a covariate of hair cortisol and mood.
The PSQI is well-established questionnaire for assessing sleep quality, duration and disturbances.
Items range from 0-3, with high scores indicating greater sleep disturbance.
|
0-2 days postpartum
|
|
Postnatal Depression
Time Frame: 0-2 days postpartum
|
Edinburgh Postnatal Depression Scale (EPDS) - The EPDS is a well-validated 10-item self-report depression screening tool, in which endorsement of each item is based on how women feel during the previous 7 days.
Possible scores range from 0 to 30, with high scores reflecting more depressive symptoms.
|
0-2 days postpartum
|
|
Postnatal Depression
Time Frame: 6 weeks postpartum
|
Edinburgh Postnatal Depression Scale (EPDS) - The EPDS is a well-validated 10-item self-report depression screening tool, in which endorsement of each item is based on how women feel during the previous 7 days.
Possible scores range from 0 to 30, with high scores reflecting more depressive symptoms.
|
6 weeks postpartum
|
|
Postnatal Depression
Time Frame: 6 months postpartum
|
Edinburgh Postnatal Depression Scale (EPDS) - The EPDS is a well-validated 10-item self-report depression screening tool, in which endorsement of each item is based on how women feel during the previous 7 days.
Possible scores range from 0 to 30, with high scores reflecting more depressive symptoms.
|
6 months postpartum
|
|
Depression, Anxiety, Stress
Time Frame: 0-2 days postpartum
|
Depression Anxiety and Stress Scales (DASS-21) - The DASS-21 will be used to measure the unique symptoms of each state.
There is normative data for the scale.
Scores range from 0-63, with higher scores indicating more severe depression, anxiety, and stress.
|
0-2 days postpartum
|
|
Depression, Anxiety, Stress
Time Frame: 6 weeks postpartum
|
Depression Anxiety and Stress Scales (DASS-21) - The DASS-21 will be used to measure the unique symptoms of each state.
There is normative data for the scale.
Scores range from 0-63, with higher scores indicating more severe depression, anxiety, and stress.
|
6 weeks postpartum
|
|
Depression, Anxiety, Stress
Time Frame: 6 months postpartum
|
Depression Anxiety and Stress Scales (DASS-21) - The DASS-21 will be used to measure the unique symptoms of each state.
There is normative data for the scale.
Scores range from 0-63, with higher scores indicating more severe depression, anxiety, and stress.
|
6 months postpartum
|
|
Mood
Time Frame: 0-2 days postpartum
|
Maternal Mood Screener (Munoz, 1988) - The mood screener questions were adapted from the Diagnostic Interview Schedule and assesses lifetime and current major depressive episode.
Positive endorsement of 5 out of 9 depression symptoms present for at least two weeks screens positive for possible major depressive episode.
The screener is a self-report checklist using the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria that has shown high concordance with the Structured Clinical Interview for DSM-IV (SCID-IV), the gold standard diagnostic interview for depression.
|
0-2 days postpartum
|
|
Mood
Time Frame: 6 weeks postpartum
|
Maternal Mood Screener (Munoz, 1988) - The mood screener questions were adapted from the Diagnostic Interview Schedule and assesses lifetime and current major depressive episode.
Positive endorsement of 5 out of 9 depression symptoms present for at least two weeks screens positive for possible major depressive episode.
The screener is a self-report checklist using the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria that has shown high concordance with the Structured Clinical Interview for DSM-IV (SCID-IV), the gold standard diagnostic interview for depression.
|
6 weeks postpartum
|
|
Mood
Time Frame: 6 months postpartum
|
Maternal Mood Screener (Munoz, 1988) - The mood screener questions were adapted from the Diagnostic Interview Schedule and assesses lifetime and current major depressive episode.
Positive endorsement of 5 out of 9 depression symptoms present for at least two weeks screens positive for possible major depressive episode.
The screener is a self-report checklist using DSM-IV criteria that has shown high concordance with the SCID-IV, the gold standard diagnostic interview for depression.
|
6 months postpartum
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability: Happy Healthy Loved Acceptability Scale
Time Frame: 6 weeks postpartum
|
Happy Healthy Loved Acceptability Scale - The investigators developed a list of 11 questions designed to assess participant satisfaction with the program on a scale of 1 (strongly disagree) to 5 (strongly agree).
Open ended responses for participants to suggest alterations to the program are included as well.
|
6 weeks postpartum
|
|
Acceptability: Happy Healthy Loved Acceptability Scale
Time Frame: 6 months postpartum
|
Happy Healthy Loved Acceptability Scale - The investigators developed a list of 11 questions designed to assess participant satisfaction with the program on a scale of 1 (strongly disagree) to 5 (strongly agree).
Open ended responses for participants to suggest alterations to the program are included as well.
|
6 months postpartum
|
|
Adherence
Time Frame: 6 months postpartum
|
Adherence will be measured by the percentage of text messages recorded as opened by participants, as well as the percentage of weekly breastfeeding check-in texts participants respond to with a yes, or no response.
|
6 months postpartum
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Marie Cooper, RN, OhioHealth
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2020
Primary Completion (Actual)
September 26, 2022
Study Completion (Actual)
March 1, 2023
Study Registration Dates
First Submitted
July 24, 2020
First Submitted That Met QC Criteria
October 1, 2020
First Posted (Actual)
October 8, 2020
Study Record Updates
Last Update Posted (Actual)
July 14, 2023
Last Update Submitted That Met QC Criteria
July 13, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 1296284
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Feeding
-
London School of Hygiene and Tropical MedicineFHI 360; AFRICSante; Centre MurazCompleted
-
The Hong Kong Polytechnic UniversityCompletedParents | Breast Feeding, ExclusiveHong Kong
-
Loma Linda UniversityNot yet recruitingPregnancy Related | Breast Feeding, ExclusiveUnited States
-
University of FloridaCompleted
-
Emel GÜÇLÜ CİHANKahramanmaras Sutcu Imam UniversityRecruitingBreast Feeding | Primiparity | Exclusive Breast Feeding | Maternal-Fetal AttachmentTurkey (Türkiye)
-
Danone NutriciaCompletedBreast Feeding | Breast Milk ExpressionChina
-
University of TurkuCompleted
-
Sakarya UniversityNot yet recruitingBreast Feeding | Feeding BehaviorTurkey
-
University of Maryland, BaltimoreWithdrawnBreast Pumping | Human Milk/BreastfeedingUnited States
-
Cumhuriyet UniversityCumhuriyet University HospitalCompletedBreast-feeding | Kangaroo Care | Comfort in Neonates | Pain in NewbornsTurkey (Türkiye)
Clinical Trials on Happy, Healthy, Loved
-
Harvard Pilgrim Health CareCenters for Disease Control and Prevention; Harvard School of Public Health...CompletedObesityCanada, United States
-
Michigan State UniversityCompletedStress | Pediatric Obesity | Healthy Diet | Intergenerational RelationsUnited States
-
Medical University of South CarolinaCompletedKidney TransplantationUnited States
-
University College CorkNational University of Ireland, Galway, IrelandNot yet recruitingDevelopmental Language Disorder and Language Impairment | DeprivationIreland
-
Northwell HealthWithdrawn
-
University of Southern DenmarkDanish Handball FederationActive, not recruitingAthletic Injuries | Adherence, Sports Injury Prevention ExercisesDenmark
-
Helsinki University Central HospitalDexCom, Inc.Not yet recruitingType1diabetes
-
Children's Hospital of PhiladelphiaNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedCritical Illness | CommunicationUnited States
-
Herbolab India Pvt. Ltd.Not yet recruitingDyspepsia | Stress | Indigestion
-
Tufts Medical CenterCompletedComplex Regional Pain Syndromes | Reflex Sympathetic Dystrophy | Amplified Musculoskeletal Pain SyndromeUnited States